+41 44 450 10 64 info@adjumed.com

Family Breast Centers / SBCDB /

EUSOMA / DKG

Here you will find the technical documentation for the breast center project with all transfer files and adaptations from previous years. The forms are generally updated once a year. If a year is missing from the list, no adjustments have been made in this period.

Project documentation

FAQs – frequently asked questions

Customizations and transfer files

Project documentation

To access the SBC database, please click on www.adjumed.net/sbcdb.
We recommend that you bookmark this link right away.

The SBCDB is under the patronage of the Swiss Cancer League and the Swiss Society for Senology. There are two contracts for the project. One between the Swiss Society of Senology and Adjumed Services AG, signed on October 27, 2011 / May 5, 2022 ( PDF). The other between the Swiss Society of Senology and the participating breast center (DOCX in German, French, Italian, to be signed by the breast center wishing to participate in the SBCDB project and sent in two copies to the Swiss Society of Senology, c/o Mrs. Karin Meyer, Bündtenweg 33, CH 4102 Binningen, Tel. + 41 79 446 86 08, info@senologie.ch).

 

FAQs on the BZ/SBCDB/EUSOMA/DKG family

Where can I find information on the quality dashboard and the structural survey form?
How can I generate the quality dashboard in AdjumedAnalyze?
  • To do this, please log in to AdjumedAnalyze at www.adjumed.net
  • Select the “Output” menu item.
  • Next, select the appropriate year
  • Then click on “SBCDB Quality Dashboard” for the output sets

You can save the dashboard as an Excel file

Is there a deadline for entering and closing SBCDB cases?
      The monitoring (quality dashboard/structural survey form) must be sent to the Cancer League office by the end of April of the following year at the latest. At least 80% of the previous year’s data must also be entered in the Adjumed database by the end of April. By the end of September, all data from the previous year’s primary cases must be completed in the Adjumed database, including follow-up data, which is collected at least once a year for each patient. The standard follow-up rate should be 70%; the target is 95%.

          Customizations and transfer files

          Adjustments 2025

          Transferfile 2025

          Transferfile SBCDB 2025

           

          SBCDB/EUSOMA adjustments as of 01.01.2025

          Dieses Jahr gibt es keine Änderungen am Fragebogen gegenüber der Version von 2024

          Adjustments 2024

          Transferfile 2024

          Transfer file SBCDB 2024

           

          SBCDB/EUSOMA adjustments as of 01.01.2024

          Dieses Jahr gibt es keine Änderungen am Fragebogen gegenüber der Version von 2023

          Adjustments 2023

          Transferfile 2023

          Transfer file SBCDB 2023

           

          SBCDB/EUSOMA adjustments as of 01.01.2023

          Der SBCDB-Fragebogen wurde komplett überarbeitet, eine visuelle Darstellung der Änderungen findet sich in folgender Präsentation: Änderungen SBCDB-Fragebogen per 01.01.2023.

          Adjustments 2022

          Transferfile 2022

          SBCDB/EUSOMA adjustments as of 01.01.2022

          • Change to the check of an existing field: The field [1096] “Plastic surgery for primary oncological operation” must be filled in if the field [1084] “N00: Patient operated on” was filled in with yes. Background: The field is evaluated for dashboard codes 14b and 14c.

          • Change to the check of an existing field: The field [1051] “D10A: Date of biopsy” must be filled in if the field [2843] “External clarification” has not been checked. Background: For internally investigated patients, the time difference between the date of the biopsy and the start of treatment is calculated.

          • New conditional-mandatory fields: The new fields [10592] “Second oncological breast operation performed?” and [10593] “Third oncological breast operation performed?” were added to the tumor statistics. The fields must be completed if the field [1084] “N00: Patient operated on” was answered in the affirmative. Background: The fields are evaluated for dashboard key figure 14a.

          • Change to the check of an existing field: The field [1117] “F05: Date of second oncological breast operation” must be filled in if the field [10592] “Second oncological breast operation performed?” was answered in the affirmative.

          • Change to the check of an existing field: The field [1132] “F38: Date of third oncological breast operation” must be completed if the field [10593] “Third oncological breast operation performed?” was answered in the affirmative.

          • Change to the check of an existing field: The field [3338] “F200 Re-operation due to complication” must be completed if a date has been entered in field [1117] “F05: Date of second oncological breast operation”. Background: The field is evaluated for dashboard code 14c.

          Adjustments 2021

          Transferfile 2021

          SBCDB/EUSOMA adjustments as of 11.06.2021 (retroactive to 2019/20)

          • Change to the master data: In field [1180] “I01: Main diagnosis”, code 6 “other incl. ypT0” was rewritten as “other”, i.e. “ypT0” was deleted.

          SBCDB/EUSOMA adjustments as of 17.02.2021 (retroactive to 2019/20)

          • New text field: If the value [2] “Rejection by patient” is selected in field [1306] “L01: Carrying out radiotherapy”, the new optional text field [8940] “Reason for treatment rejection” appears.
          • New text field: If in field [1429] “M13: Performance of neoadjuvant chemotherapy (until 2018 “M13_NEO”)” the value [2] “Refusal by patient” was selected, the new optional text field [6603] “Reason for refusal of treatment” appears.
          • New text field: If the value [2] “Refusal by patient” was selected in the field [1444] “M18: Palliative/adjuvant chemotherapy (until 2018 “M13″)” the value [2] “Refusal by patient” was selected, the new optional text field [6604] “Reason for refusal of therapy” appears.
          • New text field: If the value [2] “Rejection by patient” was selected in field [1459] “MA01: Monoclonal AK therapy performed”, the new optional text field [6605] “Reason for therapy rejection” appears.
          • New text field: If the value [2] “Rejection by patient” was selected in field [1345] “RT01: Primary antihormone therapy (neoadjuvant)”, the new optional text field [6606] “Reason for therapy rejection” appears.
          • New text field: If the value [2] “Refusal by patient” was selected in field [1387] “M01: endocrine measure (any form) administered or prescribed”, the new optional text field [6607] “Reason for therapy refusal” appears.
          • New text field: If the value [1] “Refusal by patient” was selected in field [1087] “N00A: Reason for non-operation”, the new optional text field [6608] “Reason for refusal of operation” appears.

          Adjustments during the year 2020

          • Changes to a help button: For field [1066] “D16: measured size (mm)”, only the invasive tumor portion should be specified.
          • New optional field for sentinel detection: [4877] “Magnet detection” with the codes 0 “not performed”, 1 “performed” and 9 “unknown”
          • Change to an examination: The field [2605] “D10i: Date of information on diagnostic pathology findings” no longer needs to be filled in if the patient was clarified externally, i.e. if the field [2843] “External clarification” is true.
          • In field [548 1096] “PLASTIC: Additional plastic surgery”, codes 1 “Remodeling” and 9 “unknown” have been deleted.
          • The field was also renamed “Plastic surgery for primary oncological surgery”.
          • The field [8268 1731] “L11_NEO: Radiotherapy breast” has been renamed to “L11_NEW: Radiotherapy breast”.
          • The field [8542 1505] “D08NEO: Result of aspiration cytology (until 1919 “D08″)” was renamed to “D08new: Result of aspiration cytology (until 1919 “D08″)”.
          • The field [8543 1506] “D09NEO: Punch biopsy result (breast) (until 1919 “D09″)” was renamed to “D09new: Punch biopsy result (breast) (until 1919 “D09″)”.
          • The field [2510] “Other plastic surgery” has been renamed “Plastic surgery for primary oncological surgery”.

          Turn of the year 2020

          Adjustment SBCDB/EUSOMA as of 01.01.2020

           

          • The field [1459] “MA01: Monoclonal AK therapy performed” is extended by a new, conditional-facultative field [3819] “Date of monoclonal AK therapy”, which must be filled in if the field [1459] “MA01: Monoclonal AK therapy performed” was filled in with code 1 “yes”. Affects only SBCDB.
          • The field [1297] “Her2 (FISH)” has been expanded to include code 3 “equivocal”. Affects only SBCDB.
          • The field [1306] “L01: Implementation of radiotherapy” was expanded to include code 3 “No due to comorbidity”. Affects only SBCDB.
          • Neues obligatorisches Feld [4540] “L01_NEO: Durchführung der Radiotherapie” in der Ebene A1 (Tumorstatistik). Please check the TSRF for details. Affects only EUSOMA.
          • New conditional-mandatory field [1731] “L11_NEW: Radiotherapy breast” in level A1 (tumor statistics). The field must be completed if field [1306] “L01: Radiotherapy performed” was completed with code 1 “yes”. Affects only SBCDB. Please check the TSRF for details.
          • The field [3338] “F200 Re-operation due to complication” has been expanded to include code 9 “no” and is now a mandatory field. Affects only SBCDB.
          • The field [1345] “RT01: Primary antihormone therapy (neoadjuvant)” was expanded to include code 2 “Refusal by patient”. Affects only SBCDB.
          • The field [2849] “D02: Result of mammography” was expanded to include code 7 “Patient refusal”. Affects only SBCDB.
          • The codes [50] “DOCETAXEL” and [51] “PACLITAXEL” were hidden in field [1453] “M15A: Chemotherapy regimen”. Only applies to EUSOMA.
          • New mandatory field [1739] “D13A_NEO: Clinical examination” in level A1 (tumor statistics). Only applies to EUSOMA. Please check the TSRF for details.
          • The field [1216] “I13: Pathological grading (“in situ” tumor)” was renamed “I13: Pathological grading (DCIS tumor)”. Concerns EUSOMA and SBCDB.
          • The field [2851] “D24: Preoperative conclusion recommendation to the patient” was expanded to include codes 11 “Only HT” and 12 “Only CT”. Affects only SBCDB.
          • The field [1081] “D24: Preoperative conclusion recommendation to the patient [E]” was expanded to include codes 11 “Only HT” and 12 “Only CT”. Affects only EUSOMA.
          • Code 2 “uncertain” was added to the field [1207] “I10: Lymphovascular invasion present”. Concerns EUSOMA and SBCDB.
          • Code 1a “1a” has been added to field [1252] “I29B: pN (SN)”. Concerns EUSOMA and SBCDB.
          • The field [1261] “I28: pN (final)” has been expanded to include codes 1b “1b” and 1c “1c”. Concerns EUSOMA and SBCDB.
          • The field [1036] “D08: Result of aspiration cytology” has been removed. Affects only SBCDB.
          • New mandatory field [1505] “D08new: Result of aspiration cytology (until 1919 “D08″)” in level A1 (tumor statistics). Affects only SBCDB. Please check the TSRF for details.
          • The field [1045] “D09: Punch biopsy result (breast)” has been removed. Affects only SBCDB.
          • New mandatory field [1506] “D09new: Punch biopsy result (breast) (until 1919 “D09″)” in level A1 (tumor statistics). Affects only SBCDB. Please check the TSRF for details.
          • The field [2850] “D06: Result of ultrasound” has been expanded to include code 7 “Patient refusal”. Affects only SBCDB.
          • The field [2849] “D02: Result of mammography” was expanded to include code 7 “Patient refusal”. Affects only SBCDB.

          Adjustments during the year 2019

          Adjustment SBCDB as of 08.07.2019

          Extension of audits for 2018 and 2019:

          The field [597 1243] “I25A: Minimum DCIS margin distance (mm)” only needs to be completed if the following conditions are met:

          • [544 1084] “N00: Patient operated on” = 1 (yes)
          • [2506 3337] “I25A unknown” = false (not checked)
          • [578 1186] “I03: Presence/absence of a ductal “in situ” component” = 1 (present)
          • [576 1180] “I01: Principal diagnosis” = 2 (in situ)
            NEW

          The field [596 1240] “I24: Minimum tumor margin distance (invasive)(mm)” only needs to be filled in if the following conditions are met:

          • [2504 3335] “I23: Histolog. Evaluation of the margin of the tissue section in the final histolog. Findings” = filled in
          • [2505 3336] “I24 unknown” = false (not checked)
          • [576 1180] I01: Principal diagnosis = not 2 (in situ)
            NEW

          Adjustment SBCDB as of 03.04.2019

          • Field 559 “Completing Her2 status” has been expanded to include the code 0 “Not completed”, as otherwise some cases could not be completed correctly.

          Adjustment SBCDB Quality Dashboard as of 08.03.2019

          The following filters, which are included in the SBCDB Quality Dashboard and in the benchmark report, no longer only include cases with pT = IS, but also cases with ypT = IS.

          • Filter 927: [Adj] BC Dash 18.1.0 Number of Tis
          • Filter 928: [Adj] BC Dash 18.1.1 Ant cases with breast surgery for tumors Tis
          • Filter 2366: [Adj] BC Dash 18.a Cases with [OP1246] I26: pT = IS or ypT = IS

          Adjustment SBCDB as of 01.03.2019

          • The field [4500] “Is case for SBCDB? (system)” was added to the SBCDB filter in 2018 and 2019. The new field is used to differentiate between benign and malignant cases, as only malignant cases count for the SBCDB registry. If it is a malignant case, i.e. if the code [2] “in situ”, [3] “microinvasive” or [4] “invasive” was filled in in field [1180] “I01: Main diagnosis”, the field “Is case for SBCDB? (system)” is filled with [3] “yes (automatic) ” and the field [500] “EUSOMA / DKG / SBCDB case? (for selection/export)” is automatically ticked. If the case is a benign case, i.e. if a code other than those listed above is entered in the field [1180] “I01: Main diagnosis”, the field [4500] “Is case for SBCDB? (system)” is filled with [2] “no (automatic) ” and the field [500] “EUSOMA / DKG / SBCDB case? (for selection/export)” remains empty.

            The tick in field [500] “EUSOMA / DKG / SBCDB case? (for selection/export)” can be overridden by the user by setting either [0] “No (manual)” or [1] “Yes (manual)” in field [4500] “Is case for SBCDB? (system)” by setting either [0] “no (manual) ” or [1] “yes (manual)” and saving the case.

          Turn of the year 2019

          Transferfile 2019

          Adjustment SBCDB as of 01.01.2019

          • Field 119 “Teaching assistant” becomes an optional field. The field number remains the same.
          • Field 358 “Receipt of assignment” becomes an optional field. The field number remains the same.
          • New conditional-mandatory field 559 “Final Her2 status”; level A1 (operation statistics). The field will not be included retrospectively for questionnaires before 2019. See TRSF for details.
          • Field 1072 “D20: cN” becomes a mandatory field. The field number remains the same.
          • Field 1075 “D21: Distant metastases” now only contains the codes “0” and “1”. Code “X” is no longer available for selection. The field number remains the same.
            It will still be possible to select the code “X” in earlier questionnaires or to import this code. We will gradually change the code “X” to “0” for all cases over the course of 2019.
          • Field 1189 “I05: Histology of benign lesions” becomes an optional field. The field number remains the same.
          • Field 1228 “I22: Total dimension (invasive tumor + in situ tumor) (mm)” becomes an optional field. The field number remains the same.
          • Field 1240 “I24: Minimum tumor margin distance (invasive)(mm)” becomes a conditional-mandatory field and only needs to be completed if field 3335 “I23: Histolog. Evaluation of the margin of the tissue piece in the final histolog. Findings” was filled in and the check mark was not set for field 3336 “I24 unknown”. The field number remains the same.
          • Field 1279 “ER_PERC: Percentage of ER positive cells” becomes a conditional-mandatory field and only needs to be filled in if field 1276 “I38: Presence of estrogen receptors” was filled in with master file 2 “positive”. The field number remains the same.
          • Field 1429 “M13_NEO: Performance of neoadjuvant chemotherapy” is renamed “M13: Performance of neoadjuvant chemotherapy (until 2018 “M13_NEO”)”. The field number remains the same.
          • Field 1441 “M28: Suspension of treatment due to toxicity” is renamed “M28_NEO: Suspension of treatment due to toxicity”. The field number remains the same.
          • Field 1444 “M13: Administration of chemotherapy” is renamed “M18: Administration of palliative/adjuvant chemotherapy (until 2018 “M13″)”. The field number remains the same.
          • Field 1447 “M14: Date of start of therapy” is renamed “M19: Date of start of pall/adj therapy (until 2018 “M14″)”. The field number remains the same.
          • Field 1450 “M15: Date of end of therapy” is renamed “M20: Date of end of pall/adj therapy (until 2018 “M15″)”. The field number remains the same.
          • Field 2419 “Date of neoadjuvant therapy start” is renamed “M14: Date of neoadjuvant therapy start”. The field number remains the same.
          • Field 2846 “Date of end of neoadjuvant therapy” is renamed “M15: Date of end of neoadjuvant therapy”. The field number remains the same.
          • Field 2847 “L09: RT total dose, incl. boost (Gy)” becomes a conditional-mandatory field and must only be completed if field 1327 “L13: Boost technique” was completed with the master data 1 “Electrons”, 2 “x-MV (photons)”, 3 “Intersticial brachitherapy”, 4 “Other” or 8 “Yes, unknown method”. The field number remains the same.
          • Field 2946 “L13(b): Time of boost” becomes a conditional-mandatory field and only needs to be completed if field 1327 “L13: Boost technique” has been completed with master data 1 “Electrons”, 2 “x-MV (photons)”, 3 “intersticial brachitherapy”, 4 “other” or 8 “Yes, unknown method”. The field number remains the same.

          Adjustment EUSOMA as of 01.01.2019

          • Feld 1429 «M13_NEO: Durchfuehrung einer neoadjuvanten Chemotherapie» wird aus dem SBCDB-Fragebogen übernommen und analog o.g. Änderungen umbenannt in «M13: Durchfuehrung einer neoadjuvanten Chemotherapie (bis 2018 «M13_neo»)». Die Feldnummer bleibt gleich.
          • Analogous to SBCDB: Field 1444 “M13: Chemotherapy administered” is renamed “M18: Chemotherapy administered (until 2018 “M13″)”. The field number remains the same.
          • Analogous to SBCDB: Field 1447 “M14: Date of start of therapy” is renamed “M19: Date of start of pall/adj therapy (until 2018 “M14″)”. The field number remains the same.
          • Analogous to SBCDB: Field 1450 “M15: Date of end of therapy” is renamed “M20: Date of pall/adj therapy end (until 2018 “M15″)”. The field number remains the same.
          • Feld 2419 «Datum d. neoadjuvanten Therapiebeginns» wird aus dem SBCDB-Fragebogen übernommen und analog o.g. Änderungen umbenannt in «M14: Datum d. neoadjuvanten Therapiebeginns».
          • Feld 2846 «Datum d. neoadjuvanten Therapieendes» wird aus dem SBCDB-Fragebogen übernommen und analog o.g. Änderungen umbenannt in «M15: Datum d. neoadjuvanten Therapieendes».
          • Field 563 “M18: Adjuvant chemotherapy”, field 564 “M19: Date of first adjuvant chemotherapy cycle” and field 568 “M20: Date of last adjuvant chemotherapy cycle” are deleted.

          2018 annual adjustment

          Transferfile 2018

          Adjustment SBCDB as at 31.08.2018

          Change of a field name:

          • The field [1295] “I69: Her status (immunohistochemistry)” was changed to [1295] “I69: Her2 (immunohistochemistry)”

          Modification of a test:

          • Outstanding information in field [1189] “I05: Histology of benign lesions” no longer generates error messages in connection with benign cases, but only info messages.

          Adjustment SBCDB online report as at 31.08.2018

          Deletion of two filters, as these were not meaningful due to optional fields:

          • Filter 4d1 “Complications to be operated on due to an operation in which an immediate reconstruction was performed in the same session”
          • Filter 4d2 “Complications to be operated on due to surgery without immediate reconstruction”

          Adjustment SBCDB as of 25.06.2018

          Changing the “min values”

          • Bei diversen Datums-Feldern des SBCDB-Fragebogens werden nur noch Werte ab 01.01.1980 akzeptiert um unplausible Dateneingaben/-importe auszuschliessen.

          Adjustment SBCDB as of 14.06.2018

          Modification of a test

          • The field “ypT” with field no. 3375 only needs to be filled in if the field “M13_NEO: neoadjuvant chemotherapy” (field no. 1429) was filled in with “yes” and the field “N00: patient operated on” (field no. 1084) was filled in with “yes”.

          Adjustment as of 23.04.2018

          Changes to the Quality Dashboard 2017

          • The Quality Dashboard 2017 contains a new “Derivation of figures” worksheet in which (complex) filters are broken down into their components. This should make the dashboard easier to understand and more transparent.
          • Fixed a bug in the calculation of index 18

          General adjustments

          No adjustments from 2017 to 2018.

          Adjustments SBCDB

          New field at level A1 (tumor statistics):

          • Field no. 144 “Recurrence?”: Mandatory to fill in with codes “1 – yes” / “0 – no”

          New fields at level A1 (Operation):

          • Field no. 4770 “Internal follow-up”; optional
          • Field no. 4771 “External follow-up”; optional
          • Field no. 4772 “External FU doctor”; optional
          • Field no. 4773 “FU form sent”; optional
          • Field no. 4774 “Date FU form sent”; optional
          • Field no. 4775 “FU form received”; optional
          • Field no. 4776 “Date FU form received”; optional

          All of the above fields were introduced in the “BC Aftercare (Follow Up)” filter for the years 2014-2018.

          Questions? Our hotline is here for you.

          Nous parlons aussi le Français. N'hesitez pas à nous contacter!

          +41 44 450 10 64